Mechanism of docosahexaenoic acid-induced inhibition of in vitro Aβ1-42 fibrillation and Aβ1-42-induced toxicity in SH-S5Y5 cells

Journal of Neurochemistry

Volumn 111, Issue 2, 2009, Pages 568-579

  Hossain, Shahdat ^a,b   Hashimoto, Michio ^a   Katakura, Masanori ^a   Miwa, Koji ^a   Shimada, Toshio ^c   Shido, Osamu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b JAHANGIRNAGAR UNIVERSITY   (Bangladesh)

^c SHIMANE UNIVERSITY   (Japan)

Author keywords

A 1 42 oligomer; A 1 42 peptide; Docosahexaenoic acid; Fibrillation; SH S5Y5 cells; Toxicity

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; DOCOSAHEXAENOIC ACID; DODECYL SULFATE SODIUM; POLYACRYLAMIDE GEL; THIOFLAVINE; TROMETAMOL;

ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG INHIBITION; DRUG MECHANISM; GEL ELECTROPHORESIS; IN VITRO STUDY; MICROENVIRONMENT; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CELL LINE; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT DYES; HUMANS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; NEUROFIBRILLARY TANGLES; PEPTIDE FRAGMENTS; SPECTRUM ANALYSIS; THIAZOLES;

EID: 70349311725     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06336.x     Document Type: Article

References (37)

1. Atwood C. S., Perry G., Zeng H. et al. (2004) Copper mediates dityrosine cross-linking of Alzheimer's amyloid-β. Biochemistry 43, 560 568.
2. Barnham K. J., Haeffner F., Ciccotosto G. D. et al. (2004) Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β-amyloid. FASEB J. 18, 1427 1429.
3. Bazan N. G. (2008) Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations and Alzheimer's disease. J. Lipid Res. 50, S400 S405.50 DOI :.
4. Bemporad F., Taddei N., Stefani M. Chiti F. (2006) Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase. Protein Sci. 15, 862 870.
5. Berman D. E., Dall'Armi C., Voronov S. V., McIntire L. B., Zhang H., Moore A. Z., Staniszewski A., Arancio O., Kim T. W. Di Paolo G. (2008) Oligomeric amyloid-β peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism. Nat. Neurosci. 11, 547 554.
6. Bitan G., Kirkitadze M. D., Lomakin A., Vollers S. S., Benedek G. B. Teplow D. B. (2003) Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc. Natl Acad. Sci. USA 100, 330 335.
7. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C. Glabe C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267, 546 554.
8. Clements A., Walsh D. M., Williams C. H. Allsop D. (1993) Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4 peptide. Neurosci. Lett. 161, 17 20.
9. Fraser P. E., Nguyen J. T., Surewicz W. K. Kirschner D. A. (1991) pH-dependent structural transitions of Alzheimer's amyloid peptides. Biophys. J. 60, 1190 1201.
10. Gamblin T. C., King M. E., Kuret J., Berry R. W. Binder L. I. (2000) Oxidative regulation of fatty acid induced tau polymerization. Biochemistry 39, 14203 14210.
11. Gazit E. (2002) A possible role for φ-stacking in the self-assembly of amyloid fibrils. FASEB J. 6, 77 83.
12. Glabe C. G. (2004) Conformation-dependent antibodies target diseases of protein misfolding. Trends Biochem. Sci. 29, 542 547.
13. Haass C. Selko D. J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat. Rev. Mol. Cell Biol. 8, 101 112.
14. Hashimoto M., Hossain S., Shimada T., Sugioka K., Yamasaki H., Fujii Y., Ishibashi Y., Oka J. Shido O. (2002) Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J. Neurochem. 81, 1084 1091.
15. Hashimoto M., Hossain S. Shido O. (2005a) Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid β-infused rats relates to the decreases of amyloid β and cholesterol levels in detergent-insoluble membrane fractions. Biochim. Biophys. Acta 1738, 91 98.
16. Hashimoto M., Tanabe Y., Fujii Y., Kikuta T., Shibata H. Shido O. (2005b) Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid β-infused rats. J. Nutr. 135, 549 555.
17. Hashimoto M., Shahdat H. M., Yamashita S. et al. (2008) Docosahexaenoic acid disrupts in vitro amyloid β fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats. J. Neurochem. 107, 1634 1646.
18. Innis S. M. (2007) Dietary (n-3) fatty acids and brain development. J. Nutr. 137, 855 859.
19. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N. Ihara Y. (1994) Visualization of Aβ 42(43) and Aβ 40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ 42(43). Neuron 13, 45 53.
20. Jarrett J. T., Berger E. P. Lansbury P. T. Jr. (1993) The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693 4697.
21. Kato Y., Maruyama W., Naoi M., Hashizume Y. Osawa T. (1998) Immunohistochemical detection of dityrosine in lipofuscin pigments in the aged human brain. FEBS Lett. 439, 231 234.
22. Kayed R., Head E., Thompson J. L., McIntire T. M., Milton S. C., Cotman C. W. Glabe C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486 489.
23. Kirkitadze M. D., Condron M. M. Teplow D. B. (2001) Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis. J. Mol. Biol. 312, 1103 1119.
24. Lim G. P., Calon F., Morihara T., Yang F., Teter B., Ubeda O., Salem Jr. N., Frautschy S. A. Cole G. M. (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer's mouse model. J. Neurosci. 25, 3032 3040.
25. Lukiw W. J., Cui J. G., Victor L., Marcheselli V. L., Bodker M., Botkjaer A., Gotlinger K., Serhan C. N. Bazan N. G. (2005) A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer's disease. J. Clin. Invest. 115, 2774 2783.
26. Moore S. A. (2003) Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. J. Mol. Neurosci. 16, 195 200.
27. Morris M. C., Evans D. A., Bienias J. L., Tangney C. C., Bennett D. A., Wilson R. S., Aggarwal N. Schneider J. (2003) Consumption of fish and n-3 fatty acids and risk of incident Alzheimer's disease. Arch. Neurol. 60, 940 946.
28. Padrick S. B. Miranker A. D. (2001) Islet amyloid polypeptide: identification of long-range contacts and local order on the fibrillogenesis pathway. J. Mol. Biol. 308, 783 794.
29. Podlisny M. B., Ostaszewski B. L., Squazzo S. L., Koo E. H., Rydell R. E., Teplow D. B. Selkoe D. J. (1995) Aggregation of secreted amyloid-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J. Biol. Chem. 270, 9564 9570.
30. Prasad M. R., Lovell M. A., Yatin M., Dhillon H. Markesbery W. R. (1998) Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23, 81 88. (Pubitemid 28145695)
31. Selkoe D. J. (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487 498.
32. Serpell L. C. (2000) Alzheimer's amyloid fibrils: structure and assembly. Biochim. Biophys. Acta Mol. Basis. Dis. 1502, 16 30.
33. Söderberg M., Edlund C., Kristensson K. Dallner G. (1991) Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26, 421 425.
34. Stillwell W. Wassall S. R. (2003) Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem. Phys. Lipids 126, 1 27.
35. Stine W. B., Dahlgren K. N., Krafft G. A. LaDu M. J. (2003) In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278, 11612 11622.
36. Yang F., Zhang M., Zhou B. R., Chen J. Liang Y. (2006) Oleic acid inhibits amyloid formation of the intermediate of α-lactalbumin at moderately acidic pH. J. Mol. Biol. 362, 821 834.
37. Zhu M. Fink A. L. (2003) Lipid binding inhibits α-synuclein fibril formation. J. Biol. Chem. 278, 16873 16877.